Clinical outcome and prognostic factors in renal medullary carcinoma. A pooled analysis from 18 years of medical literature.

Abstract

RMC is a tumour with poorer prognosis; based on these results, platinum-based chemotherapy is the preferred systemic treatment. Even if radical nephrectomy as an up-front strategy did not report a survival benefit, it may be considered to palliate local symptoms and to perform a correct diagnosis.